Loop Insights (TSX.V: MTRX) (OTCQB: RACMF) CEO Rob Anson has released a recent shareholder letter calling 2020 an extraordinary year and outlining the company’s significant accomplishments. A provider of contactless solutions and artificial intelligence (“AI”)…
Cybin (NEO: CYBN), a mushroom life science company, is set to leverage opportunity amid growing research that demonstrates the significant role psilocybin could play in alleviating symptoms of major depression. According to a recent study…
Net Element (NASDAQ: NETE), a financial technology company in the process of transforming its business model to become a pure-play electric vehicle (“EV”) manufacturer through a pending merger with privately-held Mullen Technologies Inc., is poised…
Analysts recommending small cap stocks for both growth and value amid large cap overvaluations, decreased momentum SRAX subsidiary LD Micro hosted 13th Annual Main Event featuring nearly 250 prominent and emerging micro-cap companies Two-day virtual…
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that it was featured in a broadcast…
Genprex (NASDAQ: GNPX), focused on developing life-changing therapies for patients with cancer and diabetes, has announced the closing of its registered direct offering of 3,116,884 shares of its common stock with a single health care-dedicated…
VistaGen (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, was featured in an equity research report by Maxim Group LLC. The piece discusses VistaGen’s…
Predictive Oncology (NASDAQ: POAI), a knowledge-driven precision medicine company focused on applying data and artificial intelligence (“AI”) to personalized medicine and drug discovery, is positioned to play a critical role in the precision oncology industry.…
Sustainable Green Team (OTC: SGTM), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, recently engaged Anthony L.G. PLLC to initiate the FORM-10 process to become fully reporting, assist with all…
Recent interview on CNBC featured prominent analyst advising investors against “egregiously expensive” tech stocks SGTM is profitable company that transforms natural waste into organic gardening products, playground surface material Recent financial results include Q3 revenue…
iClick Interactive Asia Group Limited (NASDAQ: ICLK), a China-based company, has shared the results of its annual shareholder general meeting; the meeting was held Dec. 23, 2020, in Hong Kong. During the meeting, iClick shareholders approved…
Creatd (NASDAQ: CRTD), the parent company of Vocal, has released a year-in-review overview for the proprietary technology platform. The update spotlights the creators, stories and milestones that distinguished the platform throughout 2020. In addition, the…
VistaGen (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, has announced the closing of its $100 million underwritten public offering. The offering consisted of…
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, has entered into a securities purchase agreement with a single healthcare-dedicated institutional investor. The agreement outlines…
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced the pricing of an underwritten public offering…
AzurRx BioPharma (NASDAQ: AZRX), a clinical-stage biopharmaceutical company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, recently submitted a protocol amendment request to the U.S. Food and Drug Administration (“FDA”). Approval of…
SRAX (NASDAQ: SRAX), focused on unlocking data and insights through its software-as-a-service (“Saas”) platform, Sequire, is emerging as a leader within the investor intelligence field. Launched as a stand-alone platform in early 2020, Sequire has…
Genprex (NASDAQ: GNPX), focused on developing life-changing therapies for patients with cancer and diabetes, has announced its completion of the manufacturing scale-up of REQORSA(TM) immunogene therapy. Subject to satisfactory completion of final testing currently underway,…
Energy Fuels (NYSE American: UUUU) (TSX: EFR), the largest uranium miner in the U.S., applauds the bipartisan, bicameral launch of the U.S. uranium reserve, as $75 million of funding was included in the omnibus appropriation…
The company is scheduled to conduct three clinical trials in 2021 for Berubicin – two Phase II and the first-ever Phase I in pediatric patients FDA modified the trial design to designate overall survival as…